PubRank

B Sugden

Author PubWeight™ 217.71‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Detection of two restriction endonuclease activities in Haemophilus parainfluenzae using analytical agarose--ethidium bromide electrophoresis. Biochemistry 1973 43.61
2 Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells. Nature 1985 14.39
3 A cis-acting element from the Epstein-Barr viral genome that permits stable replication of recombinant plasmids in latently infected cells. Proc Natl Acad Sci U S A 1984 10.91
4 Mammalian deoxyribonucleic acid-dependent ribonucleic acid polymerases. I. Purification and properties of an -amanitin-sensitive ribonucleic acid polymerase and stimulatory factors from HeLa and KB cells. J Biol Chem 1973 8.86
5 A vector that replicates as a plasmid and can be efficiently selected in B-lymphoblasts transformed by Epstein-Barr virus. Mol Cell Biol 1985 7.66
6 Genetic analysis of immortalizing functions of Epstein-Barr virus in human B lymphocytes. Nature 1989 7.60
7 A putative origin of replication of plasmids derived from Epstein-Barr virus is composed of two cis-acting components. Mol Cell Biol 1985 6.44
8 trans activation of an Epstein-Barr viral transcriptional enhancer by the Epstein-Barr viral nuclear antigen 1. Mol Cell Biol 1986 6.00
9 Identification and characterization of oriLyt, a lytic origin of DNA replication of Epstein-Barr virus. Cell 1988 5.76
10 Agarose slab-gel electrophoresis equipment. Anal Biochem 1975 3.88
11 Transformation of Balb 3T3 cells by the BNLF-1 gene of Epstein-Barr virus. Oncogene 1988 3.42
12 Clonal transformation of adult human leukocytes by Epstein-Barr virus. J Virol 1977 3.11
13 Transcription of simian virus 40. 3. Mapping of "early" and "late" species of RNA. Proc Natl Acad Sci U S A 1973 3.04
14 Stimulation of NF-kappa B-mediated transcription by mutant derivatives of the latent membrane protein of Epstein-Barr virus. J Virol 1995 2.91
15 Epstein-Barr virus DNA is amplified in transformed lymphocytes. J Virol 1979 2.78
16 The structure of the termini of the DNA of Epstein-Barr virus. Cell 1979 2.69
17 Nucleic acid renaturation and restriction endonuclease cleavage analyses show that the DNAs of a transforming and a nontransforming strain of Epstein-Barr virus share approximately 90% of their nucleotide sequences. J Virol 1976 2.48
18 Immortalization of human B lymphocytes by a plasmid containing 71 kilobase pairs of Epstein-Barr virus DNA. J Virol 1995 2.45
19 Establishment of an oriP replicon is dependent upon an infrequent, epigenetic event. Mol Cell Biol 2001 2.44
20 Using scenarios in chronic disease management guidelines for primary care. Proc AMIA Symp 2000 2.36
21 Identification of antigenic determinants unique to the surfaces of cells transformed by Epstein-Barr virus. Nature 1981 2.27
22 An EBNA-1-dependent enhancer acts from a distance of 10 kilobase pairs to increase expression of the Epstein-Barr virus LMP gene. J Virol 1995 2.19
23 The transforming domain alone of the latent membrane protein of Epstein-Barr virus is toxic to cells when expressed at high levels. J Virol 1989 2.13
24 EBNA-1: a protein pivotal to latent infection by Epstein-Barr virus. Rev Med Virol 2000 2.12
25 Posttranslational processing of an Epstein-Barr virus-encoded membrane protein expressed in cells transformed by Epstein-Barr virus. J Virol 1987 1.95
26 The multiple membrane-spanning segments of the BNLF-1 oncogene from Epstein-Barr virus are required for transformation. Oncogene 1989 1.94
27 Replication of plasmids derived from bovine papilloma virus type 1 and Epstein-Barr virus in cells in culture. Annu Rev Cell Biol 1987 1.93
28 Characterization of LMP-1's association with TRAF1, TRAF2, and TRAF3. J Virol 1997 1.90
29 DNA looping between the origin of replication of Epstein-Barr virus and its enhancer site: stabilization of an origin complex with Epstein-Barr nuclear antigen 1. Proc Natl Acad Sci U S A 1991 1.86
30 The PRODIGY project--the iterative development of the release one model. Proc AMIA Symp 1999 1.82
31 The linking regions of EBNA1 are essential for its support of replication and transcription. Mol Cell Biol 1999 1.80
32 The average number of molecules of Epstein-Barr nuclear antigen 1 per cell does not correlate with the average number of Epstein-Barr virus (EBV) DNA molecules per cell among different clones of EBV-immortalized cells. J Virol 1990 1.77
33 The plasmid replicon of EBV consists of multiple cis-acting elements that facilitate DNA synthesis by the cell and a viral maintenance element. EMBO J 1998 1.73
34 Comparison of Epstein-Barr viral DNAs in Burkitt lymphoma biopsy cells and in cells clonally transformed in vitro. Proc Natl Acad Sci U S A 1977 1.68
35 EBNA1 can link the enhancer element to the initiator element of the Epstein-Barr virus plasmid origin of DNA replication. J Virol 1992 1.66
36 Dominant-negative inhibitors of EBNA-1 of Epstein-Barr virus. J Virol 1997 1.59
37 Conservation and progressive methylation of Epstein-Barr viral DNA sequences in transformed cells. J Virol 1981 1.59
38 Plasmid maintenance of derivatives of oriP of Epstein-Barr virus. J Virol 1995 1.57
39 Viral DNA in transformed cells. III. The amounts of different regions of the SV40 genome present in a line of transformed mouse cells. Proc Natl Acad Sci U S A 1974 1.57
40 Inhibition by -amanitin of simian virus 40-specific ribonucleic acid synthesis in nuclei of infected monkey cells. J Virol 1972 1.56
41 Retention of plasmid DNA in mammalian cells is enhanced by binding of the Epstein-Barr virus replication protein EBNA1. J Virol 1994 1.55
42 The latent membrane protein 1 oncogene modifies B-cell physiology by regulating autophagy. Oncogene 2007 1.52
43 Optimal lengths for DNAs encapsidated by Epstein-Barr virus. J Virol 1994 1.45
44 Immortalizing genes of Epstein-Barr virus. Adv Virus Res 1991 1.45
45 Latent membrane protein of Epstein-Barr virus induces cellular phenotypes independently of expression of Bcl-2. J Virol 1993 1.44
46 Latency comes of age for herpesviruses. Cell 1988 1.44
47 Epstein-Barr virus: a human pathogen inducing lymphoproliferation in vivo and in vitro. Rev Infect Dis 1983 1.42
48 Infection of EBV-genome-negative and -positive human lymphoblastoid cell lines with biologically different preparations of EBV. Intervirology 1974 1.42
49 Multiple regions within EBNA1 can link DNAs. J Virol 1995 1.42
50 Transformation by the oncogenic latent membrane protein correlates with its rapid turnover, membrane localization, and cytoskeletal association. J Virol 1991 1.37
51 Characterization of an antigen whose cell surface expression is induced by infection with Epstein-Barr virus. J Virol 1983 1.32
52 Cloning overlapping DNA fragments from the B95-8 strain of Epstein-Barr virus reveals a site of homology to the internal repetition. J Virol 1981 1.29
53 Loss of viral gene expression and retention of tumorigenicity by Abelson lymphoma cells. J Virol 1982 1.26
54 CD40 and LMP-1 both signal from lipid rafts but LMP-1 assembles a distinct, more efficient signaling complex. EMBO J 2001 1.24
55 Antibodies to recoverin induce apoptosis of photoreceptor and bipolar cells in vivo. J Autoimmun 1998 1.22
56 The amino-terminus and membrane-spanning domains of LMP-1 inhibit cell proliferation. Oncogene 2000 1.16
57 Rep*: a viral element that can partially replace the origin of plasmid DNA synthesis of Epstein-Barr virus. J Virol 1998 1.15
58 The latent membrane protein oncoprotein resembles growth factor receptors in the properties of its turnover. Cell Growth Differ 1991 1.13
59 Transformation of lymphocytes by Epstein-Barr virus requires only one-fourth of the viral genome. Virology 1982 1.11
60 Fusions between Epstein-Barr viral nuclear antigen-1 of Epstein-Barr virus and the large T-antigen of simian virus 40 replicate their cognate origins. J Biol Chem 1998 1.09
61 Applications of oriP plasmids and their mode of replication. Methods Enzymol 1999 1.04
62 Studies on the mechanism of DNA linking by Epstein-Barr virus nuclear antigen 1. J Biol Chem 1997 1.03
63 Latent membrane protein 1 of Epstein-Barr virus inhibits as well as stimulates gene expression. J Virol 2000 1.00
64 A chimera of EBNA1 and the estrogen receptor activates transcription but not replication. J Virol 1992 0.98
65 DNA replication of herpesviruses during the lytic phase of their life-cycles. Mol Biol Med 1990 0.94
66 An EBNA-negative, EBV-genome-positive human lymphoblast cell line in which superinfecting EBV DNA is not maintained. Virology 1984 0.93
67 The molecular biology of lymphotropic herpesviruses. Adv Cancer Res 1979 0.89
68 The cis-acting family of repeats can inhibit as well as stimulate establishment of an oriP replicon. J Virol 2001 0.88
69 An identification of a transforming region of Epstein-Barr viral DNA cannot be confirmed. Virology 1985 0.88
70 Transforming functions associated with Epstein-Barr virus. J Invest Dermatol 1984 0.84
71 Characterization of the BNLF-1 oncogene of Epstein-Barr virus. Curr Top Microbiol Immunol 1989 0.83
72 Marked, transient inhibition of expression of the Epstein-Barr virus latent membrane protein gene in Burkitt's lymphoma cell lines by electroporation. J Virol 1993 0.83
73 Dissociation of patching by latent membrane protein-1 of Epstein-Barr virus from its stimulation of NF-kappaB activity. J Gen Virol 1999 0.80
74 Epitope recognition and T cell receptors in recurrent autoimmune anterior uveitis in Lewis rats immunized with myelin basic protein. J Neuroimmunol 2000 0.77
75 Importance of cryptic myelin basic protein epitopes in the pathogenicity of acute and recurrent anterior uveitis associated with EAE. J Neuroimmunol 2001 0.76
76 The TextBase project--implementation of a base level message supporting electronic patient record transfer in English general practice. Proc AMIA Symp 1999 0.75
77 Epstein-Barr virus. Synthesis for a complex role. Nature 1989 0.75
78 Instrument shadow boards. Nurs Mirror Midwives J 1967 0.75
79 Howard M. Temin: December 10, 1934-February 9, 1994. Biogr Mem Natl Acad Sci 2001 0.75
80 Viral RNA in cells carring Epstein-Barr virus. IARC Sci Publ 1975 0.75
81 Nitrogen turnover in man. JPEN J Parenter Enteral Nutr 1980 0.75